Why Is Defense Money Saving a Struggling Chipmaker?

NEW YORK — The Pentagon just became the most consequential venture capitalist in the silicon carbide market, and one beaten-down chipmaker is trading like it.

NEW YORK, October 8, 2026 — U.S. equities opened in the red Thursday, with the S&P 500 slipping 0.22% to 7,792.98, the Dow Jones Industrial Average falling 0.25%, the Nasdaq Composite retreating 0.30% to 27,518.13, and the Russell 2000 underperforming sharply with a 1.31% loss. The broad tape was soft, but three stocks with hard catalysts were moving against the current — and one of them carried a government checkbook.

Opening Bell Standout — Wolfspeed: When the Pentagon Writes the Check

Wolfspeed (WOLF) opened at $35.89, up 14%, after the U.S. Department of Defense announced a conditional commitment for up to $1.5 billion in long-term financing to support domestic production of silicon carbide materials and wide bandgap power devices. The commitment carries a 30-year term — an unusually long duration that signals the Pentagon views silicon carbide supply chain security as a generational infrastructure problem, not a procurement line item.

Shares had already jumped 19.86% to $37.60 in Wednesday’s after-hours session and held much of that gain through premarket at $35.44. The open at $35.89 represented a consolidation of the spike rather than a reversal — which matters. Stocks that hold 70% or more of an after-hours move into the open are typically seeing institutional participation, not just retail excitement.

Under the deal terms, Wolfspeed will issue the DoD warrants to purchase up to 7.5% of shares in tranches. That dilution component deserves more scrutiny than the market has given it this morning. A 7.5% warrant overhang from a non-commercial counterparty is not standard venture structure — it is government as equity participant, which creates uncertainty around future capital raises and M&A optionality.

Data Visual

Wolfspeed (WOLF) Price Progression: After-Hours Through Open

Shows how WOLF shares moved from Wednesday’s prior close through after-hours and into Thursday morning trading, illustrating the scale and persistence of the Defense loan catalyst.

Values in $

Haemonetics: A Quieter Pop With a Cleaner Story

While WOLF commanded the headline, Haemonetics (HAE) delivered arguably the cleaner catalyst. Shares opened near $120.00, up roughly 18% from Wednesday’s close of $101.71, after CSL Limited announced it will deploy Haemonetics’ NexSys PCS devices across all U.S. plasma collection centers by the end of 2027. This is not a pilot. This is a full-network rollout — and that distinction matters enormously for revenue visibility.

CSL operates one of the largest plasma collection networks in the United States. A commitment to standardize on Haemonetics’ NexSys platform with Persona PLUS technology across every U.S. center by December 2027 locks in a multi-year revenue stream with a counterparty that has minimal credit risk. For HAE, which has traded choppily through mid-year, this is the kind of contract clarity that re-rates a stock — not just moves it for a session.

The analyst community was already constructive. Eleven analysts carried a consensus Buy rating on HAE with an average price target of $111.50 — which Thursday’s open has already exceeded. Raymond James’ Andrew Cooper had maintained a Buy at $125, and Citi’s Joanne Wuensch upgraded to Buy with a $123 target in September. The open near $120 puts HAE within striking distance of the top of the Street’s target range, which raises the question: how much upside is left if buy-side models were already pricing in favorable plasma contract momentum?

The Broader Tape: Small Caps Bear the Weight

Away from the individual movers, the macro picture was less encouraging. The Russell 2000’s -1.31% opening loss stood out against the large-cap benchmarks’ more modest declines. Small-cap underperformance at this magnitude relative to the S&P 500 often signals risk-off rotation rather than simple profit-taking — traders moving up the quality curve, not merely trimming exposure. As we noted earlier this week, the question of whether the 7,800 level can hold when only 27% of stocks are participating has not been resolved, and today’s Russell divergence adds weight to that concern.

Data Visual

October 8 Index Opening Performance: All Four Major Benchmarks

Compares the percentage change at the open across S&P 500, Dow Jones, Nasdaq, and Russell 2000, highlighting the outsized small-cap underperformance.

Values in %

Goldman Sachs’ upgrade of Palantir (PLTR) from Neutral to Buy with a 12-month price target of $230 — representing approximately 18% upside from Wednesday’s close of $194.12 — added a third catalyst-driven name to the session. Analyst Gabriela Borges argued that sovereign AI demand and custom application development could expand Palantir’s addressable market well beyond current Street models. That is a conviction call, not a maintenance, and those tend to move more institutional paper. PLTR’s trajectory this session is worth tracking as a proxy for how seriously the buy-side is taking the sovereign AI thesis right now.

The broader yield environment remains a headwind that stock-specific catalysts cannot fully offset. Bond yields have been asserting themselves against this rally in ways that the tape has not fully priced — and small-cap weakness this morning may be the clearest expression of that pressure yet. Meanwhile, jobless claims data released this morning adds another variable traders must weigh before positioning into the afternoon.

The Level That Decides the Morning

For WOLF, the first-hour test is whether the $33.00 level holds. A sustained break below that would indicate that the after-hours gap was driven by short-covering rather than fresh long positioning — and that the stock needs time and analyst re-rating before it can build a durable base. Holding $33.00 with volume moderating suggests the institutional community is absorbing supply at these levels, which is a constructive signal for a push toward the $38.00 resistance zone created by the after-hours high.

For HAE, the $115.00 level is the line in the sand. The stock opened above the highest analyst price target on the Street. Any fade that holds $115.00 on the first retest would suggest the market is repricing fair value above consensus — a legitimate outcome given the contract scope. A break below $115.00 would put the stock back within the existing target range and invite profit-taking from traders who positioned into the announcement overnight.

Three stocks with genuine catalysts are moving against a soft tape Thursday morning — but the broader context is fragile. The Russell 2000 at -1.31% is not a noise print; it is small-cap investors voting with their feet in a yield-pressured environment. The government-backed WOLF trade is real, but it is a financing story, not a revenue story, and those distinctions have a way of asserting themselves once the initial gap fades. HAE is the cleaner fundamental setup. And Palantir’s Goldman upgrade, timed to a sovereign AI narrative that is still in early innings, may prove the most durable of the three. Watch the S&P 500 at 7,780 — a sustained break below that level with continued Russell weakness would confirm that today’s movers are anomalies in a deteriorating tape, not the leading edge of a recovery.